BRUNI, Alessio
 Distribuzione geografica
Continente #
AS - Asia 3.977
NA - Nord America 2.827
EU - Europa 1.236
SA - Sud America 593
AF - Africa 70
OC - Oceania 7
Totale 8.710
Nazione #
US - Stati Uniti d'America 2.715
CN - Cina 1.287
SG - Singapore 1.127
VN - Vietnam 499
BR - Brasile 452
IT - Italia 396
HK - Hong Kong 359
KR - Corea 221
GB - Regno Unito 172
TR - Turchia 162
FI - Finlandia 133
DE - Germania 95
SE - Svezia 88
FR - Francia 78
IN - India 62
ID - Indonesia 57
AR - Argentina 48
BD - Bangladesh 48
MX - Messico 46
RU - Federazione Russa 45
UA - Ucraina 44
CA - Canada 35
NL - Olanda 35
BG - Bulgaria 26
ES - Italia 25
IQ - Iraq 25
CO - Colombia 23
EC - Ecuador 21
BE - Belgio 20
JP - Giappone 20
PL - Polonia 19
CL - Cile 17
ZA - Sudafrica 17
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
MY - Malesia 13
VE - Venezuela 11
DZ - Algeria 10
PY - Paraguay 10
EG - Egitto 9
IE - Irlanda 8
KE - Kenya 8
SA - Arabia Saudita 8
NP - Nepal 7
AL - Albania 6
AU - Australia 6
IL - Israele 6
LT - Lituania 6
PE - Perù 6
PH - Filippine 6
RO - Romania 6
TH - Thailandia 6
TN - Tunisia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
JO - Giordania 5
PA - Panama 5
AT - Austria 4
BZ - Belize 4
HU - Ungheria 4
IR - Iran 4
MA - Marocco 4
QA - Qatar 4
RS - Serbia 4
UZ - Uzbekistan 4
BO - Bolivia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
HN - Honduras 3
KZ - Kazakistan 3
LU - Lussemburgo 3
SN - Senegal 3
TG - Togo 3
TT - Trinidad e Tobago 3
CH - Svizzera 2
CY - Cipro 2
JM - Giamaica 2
PR - Porto Rico 2
SI - Slovenia 2
TW - Taiwan 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
Totale 8.696
Città #
Hefei 779
Singapore 632
Ashburn 392
Hong Kong 349
San Jose 264
Santa Clara 251
Seoul 221
Fairfield 211
Ho Chi Minh City 168
Istanbul 130
Hanoi 124
Helsinki 121
Beijing 114
Council Bluffs 103
Houston 86
Los Angeles 86
Chandler 76
Wilmington 76
Woodbridge 76
Seattle 73
London 70
Lauterbourg 64
Cambridge 63
Shanghai 62
Chicago 54
Modena 50
Kent 46
Buffalo 42
Southend 41
Dallas 38
Nyköping 38
São Paulo 37
The Dalles 34
New York 30
Milan 29
Salt Lake City 28
Orem 27
Mexico City 26
Ann Arbor 25
Da Nang 24
Jakarta 24
Rome 22
Princeton 21
Sofia 21
Dearborn 20
Frankfurt am Main 19
Haiphong 19
San Diego 19
Tokyo 17
Warsaw 17
Boardman 16
Bologna 14
Brooklyn 14
Chennai 14
Jacksonville 14
Leuven 14
Munich 14
Turin 14
Biên Hòa 13
Dhaka 13
Denver 12
Johannesburg 12
Lappeenranta 12
Montreal 12
Reggio Emilia 12
Rio de Janeiro 12
Baghdad 11
Eugene 11
Osasco 11
Poplar 11
Izmir 10
Las Vegas 10
Nuremberg 10
Phoenix 10
Shenzhen 10
Tampa 10
Brasília 9
Curitiba 9
Elk Grove Village 9
Manchester 9
Moscow 9
Portsmouth 9
Santiago 9
Ankara 8
Stockholm 8
Thái Nguyên 8
Tilburg 8
Toronto 8
Verona 8
Falkenstein 7
Florence 7
Guarulhos 7
Mudanya 7
Mumbai 7
Naples 7
Quito 7
Amsterdam 6
Asunción 6
Bremen 6
Buenos Aires 6
Totale 5.859
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 308
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 298
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 280
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 259
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 251
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 206
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 198
SIS epidemiological model for adaptive RT: Forecasting the parotid glands shrinkage during tomotherapy treatment 181
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 179
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 166
Pineoblastoma in Adults: A Rare Case Successfully Treated with Multimodal Approach Including Craniospinal Irradiation Using Helical Tomotherapy 156
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 156
Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation 139
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 138
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis 133
Lattice Radiation Therapy in clinical practice: A systematic review 132
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients 132
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 129
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation 127
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 127
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 123
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 121
Quality of life after prostate cancer diagnosis: Data from the Pros-IT CNR 118
Guidelines on prostate carcinoma - AIRO, 2016 117
The role of postoperative radiotherapy for thymomas: a multicentric retrosepective evaluation from three Italian centers and review of the literature. 117
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 114
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 114
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 113
Erratum: The role of postoperative radiotherapy for thymomas: A multicentric retrospective evaluation from three Italian centers and review of the literature (Journal of Thoracic Disease (2020) 12 (7518-7530) DOI: 10.21037/jtd-2019-thym-09) 113
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study 110
A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC 105
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 105
Response to Letter to the Editor Titled “Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?” 105
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 103
Non-invasive approach to treat primary solid solitary pulmonary nodule: a narrative review by the radiation oncologist perspective 101
Current radiotherapy techniques in NSCLC: challenges and potential solutions 97
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 96
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 96
Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial 96
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 94
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national patterns-of-practice (pop) database by the uro-oncology study group of the italian society of radiotherapy and clinical oncology (airo) 94
Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study 93
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 92
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 89
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 88
Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach 87
Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy 87
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 87
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 86
Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial 85
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study 85
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 83
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 80
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 80
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC 80
Radiosurgery Using Tomotherapy for Patients with Brain Oligo-metastasis: A Retrospective Analysis on Feasibility and Tolerance 79
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach 79
Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings 78
Brain metastases from primary colorectal cancer: Is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 75
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 74
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 69
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 69
Radiotherapy Timing in 4,820 Patients With Breast Cancer: University of Florence Experience 69
Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer 67
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 65
Post-operative radiotherapy in N2 non-small cell lung cancer: A retrospective analysis of 175 patients 64
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 62
Oral ibandronate in metastatic bone breast cancer: The Florence University experience and a review of the literature 62
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 62
Reirradiation in head and neck recurrent or second primary tumor: Efficacy, safety, and prognostic factors 61
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 60
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO 60
Management of Stage II testicular seminoma over a period of 40 years 56
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 56
Radiotherapy timing in the treatment of limited-stage small cell lung cancer: The impact of thoracic and brain irradiation on survival 56
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: A retrospective analysis 51
Radiation therapy in small cell lung cancer: a national Italian survey 50
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)—Lung Working Group 49
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 46
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC Study 39
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 39
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 38
Locally advanced NSCLC: overview of real-world pattern of recurrence in durvalumab era (LEOPARD trial) 37
Totale 8.821
Categoria #
all - tutte 32.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.190


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021105 0 0 0 0 0 0 0 0 0 40 50 15
2021/2022405 59 25 15 15 14 25 27 31 39 31 93 31
2022/2023294 38 37 40 15 40 31 5 20 40 2 10 16
2023/2024257 18 13 24 31 21 12 22 40 8 15 15 38
2024/20251.715 30 2 17 62 158 133 46 78 171 314 355 349
2025/20265.390 505 406 702 791 607 406 609 305 662 397 0 0
Totale 8.821